Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-13 09:58:44 EDT

Explore

PostsPeople
LatestRanked
Load more
@shipyardmaster64.bsky.socialSep 24, 2026, 8:26 PM

#Obesity #Diabetes personally I think part of the issue is that people eat nostalgically they shop at supermarket nostalgically. so nutritionally they are still children. some of them should and you know better some fall victim to Madison Avenue, regardless American diet suck

@microbesinfect.bsky.socialSep 24, 2026, 6:44 PM

A commensal-derived sugar protects against #obesity by regulating immunometabolism.

Clostridium immunis sugar lowers IL‑22 to boost visceral fat burning and counter obesity.

www.sciencedirect.com/science/arti... #microbiota #immunity #metabolism #MicroSky #ImmunoSky #MedSky

Photo, no description
@tfah.bsky.socialSep 24, 2026, 4:18 PM

TFAH’s new report shows 21 states had adult #obesity rates above 35% in 2025, up from the previous year. https://www.tfah.org/report-details/state-of-obesity-2026/

@tickerade.bsky.socialSep 24, 2026, 3:11 PM

📉 Viking Therapeutics #VKTX is facing after-hours pressure despite a recently completed equity raise with ~5% dilution and promising VK2735 obesity-treatment data, as dark-pool activity signals investor caution.
#clinicaltrials #obesity

Photo, no description
@newsen.bsky.socialSep 24, 2026, 12:31 PM

New Global Initiative by Boehringer Ingelheim and WHO Foundation to Tackle Obesity and Metabolic Health #Boehringer_Ingelheim #Switzerland #obesity #Geneva #WHO_Foundation

@newsen.bsky.socialSep 24, 2026, 12:30 PM

Boehringer Ingelheim and WHO Foundation Join Forces to Tackle Obesity Worldwide #USA #Boehringer_Ingelheim #obesity #Geneva #WHO_Foundation

@4040rec.bsky.socialSep 24, 2026, 8:52 AM

#Novo #obesity #patentprotection #Wegovy #weightloss #Ozempic #diabetes #CagriSema #Foundayo #Haematology #haemophiliaA #Frehemgo #sicklecelldisease #PNH #blooddisorders #endocrinedisorders #liverdiseases #cardiovasculardisease #consumerRx #pain #addiction #menshealth #womenshealth
zurl.co/Lmdba

@thelancetendo.bsky.socialSep 24, 2026, 7:48 AM

Marcel H A Muskiet & colleagues comment on:
The #glucagon renaissance in #obesity therapeutics www.thelancet.com/journals/lan...

#MedSky #EndoSky

@thelancetendo.bsky.socialSep 24, 2026, 7:48 AM

Multihormone receptor modulators that include #glucagon receptor agonism—such as #mazdutide—could provide novel & effective alternatives for weight management, further expanding the options available for optimised treatment of individuals with #obesity www.thelancet.com/journals/lan...

#MedSky

@fllics.comSep 24, 2026, 7:00 AM

India tightens school junk food rules amid obesity rise

India proposes banning junk food sales in school canteens and within 50 meters of schools to curb rising obesity and diabetes rates among children. #News #Reuters #Newsfeed #india #obesity #diabetes #children #school #junkfood #diet…

@kill-bait.bsky.socialSep 24, 2026, 4:48 AM

Type 2 diabetes linked to rising cancer incidence, especially obesity-related cancers

🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅

#diabetes #cancer #obesity

👇👇👇

@sablesystems.bsky.socialSep 23, 2026, 5:03 PM

Join us at the #AdiposeBiology #Conference in 2 weeks! (Oct 7–9, Montreal, Canada)

Sable Systems is a proud partner of this exciting event. 😁

buff.ly/8qNkkHR

#Metabolism #Physiology #Respirometry #IndirectCalorimetry #Obesity #Thermogenesis

Photo, no description
@pharmaj.bsky.socialSep 23, 2026, 3:30 PM

Around one in six children taking glucagon-like peptide-1 receptor agonists experiences a nutritional deficiency within the first year of treatment, according to the results of a US study

#ukpharmacy #obesity #GLP-1

buff.ly/0x4Ar6m

@iocbtech.bsky.socialSep 23, 2026, 1:25 PM

What if there would be a treatment for #obesity & #osteoporosis in women after #menopause? @IOCBTech has a program exactly addressing this problem - ready for #investments

Presenting at #PragueBio2026 #PharmTheon

Photo, no descriptionPhoto, no description
@toppnews.bsky.socialSep 23, 2026, 1:20 PM

#abuse #Hong Kong #obesity #victim #victims
🌐 www.newsmart.ch

@dataforindia.bsky.socialSep 23, 2026, 3:30 AM

🧵 Obesity is rising in India. In 2021, almost a quarter of adults aged 15–49 were overweight or obese. By 2024, this figure had reached nearly 30%.

#Obesity #Overweight #Health #DataForIndia #India

Title: A quarter of all Indian adults are overweight or obese Sub-title: Share of overweight and obese men and women across sector (2021) Explanation: Overweight and obesity were more common in urban India than in rural India. Among urban adults, 30% of men and 34% of women were overweight or obese. In rural areas, the corresponding shares were 19% for both men and women. Obesity alone was most prevalent among urban women, at 11%. Source: National Family Health Survey, International Institute for Population Sciences Attribution: Data For India | CC BY
@endocrinesociety.bsky.socialSep 22, 2026, 9:00 PM

President’s Viewpoint: Nanette Santoro, MD, discusses addressing obesity. “Obesity and its underlying hormonal dysfunctions are so important to our field that the Endocrine Society recognizes it as a key organizational pillar.” Read her perspective: https://bit.ly/4xB5sME #Obesity

@pharmalot.bsky.socialSep 22, 2026, 1:52 PM

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more news.. www.statnews.com/pharmalot/20... #pharma #biotech #China #obesity #weight #antitrust #Russia #Teva #Regeneron

@bigearthdata.aiSep 22, 2026, 1:35 PM

Poor sleep health in late pregnancy linked to higher childhood obesity risk
->News-Medical | More on "Pregnancy sleep and childhood obesity" at BigEarthData.ai | #Obesity #Health

@midgardfinance.comSep 22, 2026, 1:30 PM

💉 #obesity

🇩🇰 Novo Nordisk's #CagriSema beat 🇺🇸 Eli Lilly's tirzepatide in REIMAGINE 5: 12.4% against 9.1% weight loss at 60 weeks in type 2 diabetes.

At 1.0/1.0 mg, against tirzepatide's lowest 5 mg. The three head-to-heads fought at top dose all went to Lilly.

$NOVO $LLY

Horizontal bar chart of the four head-to-head trials that put a Novo Nordisk incretin against an Eli Lilly one, oldest readout at the top, weight loss at the primary endpoint on a scale from zero to about 34 per cent. Each trial has two bars, the Novo arm in blue above the Lilly arm in red, and each bar is labelled with the drug, its dose and its result. Each row also says whether the arms were at their top dose. SURMOUNT-5, obesity, 72 weeks, 2025, won by Lilly, both at top dose in 2025: semaglutide 2.4 mg 13.7 per cent against tirzepatide 15 mg 20.2 per cent. REDEFINE 4, obesity, 84 weeks, February 2026, won by Lilly, both at top dose: CagriSema 2.4/2.4 mg 23.0 per cent against tirzepatide 15 mg 25.5 per cent. ACHIEVE-3, type 2 diabetes, 52 weeks, March 2026, won by Lilly, both at top dose: oral semaglutide 14 mg 5.3 per cent against orforglipron 36 mg 8.2 per cent. REIMAGINE 5, type 2 diabetes, 60 weeks, September 2026, won by Novo, neither at top dose: CagriSema 1.0/1.0 mg 12.4 per cent against tirzepatide 5 mg 9.1 per cent, the only row where the blue bar is longer than the red one.